PRO51 COST-EFFECTIVENESS AND BUDGET IMPACT OF ONASEMNOGENE...

Value in Health 2019 / 11 Vol. 22

PRO51 COST-EFFECTIVENESS AND BUDGET IMPACT OF ONASEMNOGENE ABEPARVOVEC FOR SPINAL MUSCULAR ATROPHY TYPE 1: POST-HOC ANALYSIS OF A MODEL DEVELOPED BY ICER

Dabbous, O., Dean, R., Arjunji, R., Sproule, D.M., Feltner, D.E., Malone, D.C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.2381
Date:
November, 2019
File:
PDF, 323 KB
2019
Conversion to is in progress
Conversion to is failed